chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I started feeling like I couldn't swallow very well and my neck felt swollen for a week. My lymph nodes started swelling on my Neck and Clavicle. I wasn't sure of what to do so I called the pharmacy and that's when I signed up for the smartphone based app. Eventually the swelling went down a little, but not completely so I saw my Dr. a couple months after. My doctor wanted me to get an Ultrasound and a CT, but I wasn't able to. They are still a little swollen now but those ordered tests have now expired.
Fever, body aches, arm soreness that is now CoVid-Arm, fatigue
This spontaneous case was reported by a patient and describes the occurrence of DISABILITY (Patient stated she was very sick and disabled) and ILLNESS (Very sick) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DISABILITY (Patient stated she was very sick and disabled) and ILLNESS (Very sick). At the time of the report, DISABILITY (Patient stated she was very sick and disabled) and ILLNESS (Very sick) outcome was unknown. No concomitant information was reported. It was reported that patient wanted a nurse to go to her home to provide her another dose. No treatment information was provided.
COVID-19; COVID-19; This is a solicited report received from contactable reporter(s) (Consumer or other non HCP) for a sponsored program. The reporter is the patient. Other Case identifier(s): 22K-163-4294209-00.  A 69 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administration date 25Oct2021 (Batch/Lot number: unknown) at the age of 68 years as dose 3 (booster), single, intramuscular, administration date 25Mar2021 (Batch/Lot number: unknown) as dose 2, single and intramuscular, administration date 04Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation; adalimumab (HUMIRA), subcutaneous (Batch/Lot number: unknown) at unk(citrate free) for psoriatic arthropathy. The patient's relevant medical history and concomitant medications were not reported.The following information was reported: VACCINATION FAILURE (medically significant) with onset 27Oct2021, outcome "unknown", COVID-19 (medically significant) with onset 27Oct2021, outcome "recovered" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (27Oct2021) positive, notes: experienced COVID-19. The action taken for adalimumab was unknown. Therapeutic measures were taken as a result of covid-19.  Clinical course:The patient had been sick since Dec2021, primary care physician referred the patient to the specialist physician to check her knees which were pretty worn out (bone on bone) and physician proposed knee replacement. She had pain and had gout for three months. Causality for Humira (Adalimumab):The reporter's causality for the event(s) of knees bone on bone worn out, sick and pain with Humira (Adalimumab) was a reasonable possibility and gout was not provided.The reporter's causality for the event(s) of knees bone on bone worn out, sick, Gout and pain with Pfizer BioNTech covid-19 vaccine was not reported. Causality for COVID-19:As per reporter (Drug/Vaccine): Possible.  The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of serious events vaccination failure and COVID-19 cannot be totally excluded.
1835 Given flu shot ? first time. Asked to sit in wait room. 1840 In wait room sweaty - nauseous, dizzy, pale. Walked to exam room. BP 94/40. 1845 Pt w/ increased dizziness, nausea, hands tingling. Given 50mg BENADRYL, ice pack to back of neck. 1850 Pt feeling better BP 100/60. 1900 BP 124/70, HR 88.
Within 5 minutes of vaccination, patient developed cough and vomiting. He was brought back to a patient room where widespread urticarial lesions developed on his face, trunk and extremities.  He was placed on oxygen 10Lpm rebreather mask due to respiratory distress and hypoxemia (pulse ox 83%), epinephrine 0.15 mg IM administered, EMS was called, diffuse wheezing noted on exam, oral benadryl administered, diffuse erythema of skin was noted and swelling of bottom lip, a second dose of epi 0.15mg was administered.  EMS arrived and patient was taken to the Emergency Department for further management.
Staff member gave these three vaccines to pt. at 8 months old. He was not old enough for these shots to be given to him.
having an episode of shingles, for the 5th time! I've had all the shots too./Suspected vaccination failure; Shingles; Bad enough to scream through the pain; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix and the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix and Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. The patient was treated with medication unknown. On an unknown date, the outcome of the vaccination failure and pain were unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingrix and Shingrix.     Additional Information: GSK Receipt Date: 25-AUG-2022 Reporter's Comment: This case was reported by the patient via interactive digital media. The patient received both doses of Shingrix vaccine a long time ago from reporting. The patient was currently having an episode of shingles, for the 5th time. The patient stated after received all shots you could still get shingles, but it was a milder case, still miserable though. The patient was currently on medication for Shingles. The patient stated hate to think how bad it would be without the Shingrix vaccines. The patient stated that the breakthrough episodes were not bad but still bad enough to scream through the pain. The patient stated you could still get the shingles, but just a milder and shorter case of it. The doctor puts patient on medicine for each time. Additional supportive information: This case was considered as suspected vaccination failure as details regarding time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
During the last 10 years I have been suffering from legs mussles pain . I have seen many top doctors from differnt fields , checked all my body organs. The cause of the pain was not found .  The vaccsine I received on 11/22 totaly relieved my pain for about 2 months , during which I could walk and run like I have done for 10 years .  Everesince , I have been trying to find out which of the components of the vaccsin eliminated my pain.  I will be forever greatfull if you could help mr find the componnent of thr vaccsin the relieved my leg pain.  Thank you.
Since receiving second dose of vaccine:      heart palpitations in a rest state, almost daily      heaviness in chest when in a recline position; every time      one hard heart beat, few times a week Have been trying to give body/heart time to adjust to vaccines before seeking medical advise/attention.
The Medical Assistant reported a temperature excursion for refrigerated vaccine.; This spontaneous report was received from a Medical Assistant referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications, and historical drugs were not reported.  On 12-MAR-2021, the patient was vaccinated with an improperly stored dose of hepatitis rotavirus vaccine, live, oral, pentavalent(ROTATEQ) dose 1 (units not provided), per oral route (strength, dose, frequency, and anatomical location were unknown) with lot # 1691301 and expiration date 12-DEC-2021 for prophylaxis.The patient was asyntomatic.  The administered dose of vaccine experience the temperature excursion on one of these dates, 22-FEB-2021, 25-FEB-2021, 02-MAR-2021, 05-MAR-2021, 09-MAR-2021, 15-MAR-2021, and 19-MAR-2021, of 35.6, 35.7, or 35.9  degrees Fahrenheit for 15 minutes; on 17-MAR-2021, the temperature excursion of 35.7 degrees Fahrenheit for 30 minutes;  on 18-MAR-2021 and 28-MAR-2021, of 35.2 and 35.9 degrees Fahrenheit for 45 minutes; on 25-MAR-2021, of 35.2 degrees Fahrenheit for 4 hours and 15 minutes; on 26-MAR-2021, of 35.4 degrees Fahrenheit for 2 hours and 45 minutes; or on 27-MAR-2021, of 35.9 degrees Fahrenheit 1 hour and 30 minutes.  There was no digital data logger involved, and no previous temperature excursion. The Vaccines for Children (VFC) program did an audit, and they were unaware of the excursions.  This is one of several reports received from the same reporter.. ; Sender's Comments:  US-009507513-2105USA002850: US-009507513-2105USA003496: US-009507513-2105USA003497: US-009507513-2105USA003498: US-009507513-2105USA003499: US-009507513-2105USA003500: US-009507513-2105USA003501: US-009507513-2105USA003502: US-009507513-2105USA003503: US-009507513-2105USA003504: US-009507513-2105USA003505: US-009507513-2105USA003506: US-009507513-2105USA003507: US-009507513-2105USA003508: US-009507513-2105USA003509: US-009507513-2105USA003510: US-009507513-2105USA003511: US-009507513-2105USA003512: US-009507513-2105USA003513: US-009507513-2105USA003514: US-009507513-2105USA003515: US-009507513-2105USA003516: US-009507513-2105USA003517: US-009507513-2105USA003518: US-009507513-2105USA003519: US-009507513-2105USA003520: US-009507513-2105USA003521: US-009507513-2105USA003522: US-009507513-2105USA003523: US-009507513-2105USA003524: US-009507513-2105USA003525: US-009507513-2105USA003526: US-009507513-2105USA003527: US-009507513-2105USA003528: US-009507513-2105USA003529: US-009507513-2105USA003530: US-009507513-2105USA003531: US-009507513-2105USA003532: US-009507513-2105USA003533: US-009507513-2105USA003534: US-009507513-2105USA003535: US-009507513-2105USA003536: US-009507513-2105USA003538: US-009507513-2105USA003539: US-009507513-2105USA003540: US-009507513-2105USA003541: US-009507513-2105USA003542: US-009507513-2105USA003543:
pt started screaming, vomited, whole body turned red, trouble breathing & shaking;pt admitted 26NOV96;27NOV96 lungs clear, taking formula afeb;
chills; 101 fever; tired; This case was reported by a consumer via interactive digital media and described the occurrence of chills in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced chills, fever and tiredness. On an unknown date, the outcome of the chills, fever and tiredness were not recovered/not resolved.   It was unknown if the reporter considered the chills, fever and tiredness to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 01-NOV-2022 Reporter's Comments:  The case was reported via interactive digital media. The patient asked as how long the side effects would last with the second dosage.  At the time of reporting, he/she had chills, fever (101) and tired. Additional Supportive Information: Follow up would not possible, as no contact details were available.
Extremely rash that has spread all over body and is very itchy. Still very extreme. Was referred to an allergist to do testing on Tuesday february 16th. Nothing is relieving symptoms.
Nerve pain in all limbs (right side of body worse than left), Tingling in 4th and 5th fingers bilaterally (right side worse than left), Tingling in middle three toes right side, Joint pain in multiple joints (including knees, hips, ankle, shoulders, etc). Doctors have ruled out many other conditions and have not found anything to explain these symptoms yet. Symptoms started July 23, 2021 and have gradually spread and worsened. Symptoms have lasted 6 months so far and caused a 3 day hospital stay in August/September. Previous treatment included a 10 day course of prednisone taper in August/September 2021. Current treatment include gabapentin, vitamin D, meloxicam, cymbalta, and physical therapy.
shingles; This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a 57-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 24th June 2019, the patient received the 1st dose of Shingrix. On 29th July 2019, 35 days after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The reporter had consented to follow up.
Minor to mild cerebrovascular pressure around tbi and frontal lobe. Minor lymphadenopathy in rear neck and flanks and legs. Pain/pressure and swelling in those areas. Onset around 0-2 months after second dose and still present currently.
Site pain and swelling, body pain, dizziness, chills, slight fever, headache, nausea, vomiting, diarrhea, fatigue, disoriented, cannot work.  On third day of this.
Administered at 10 AM October 6, 2005. Chills with shakes started at 3 PM, lasted 2 hrs. followed by high fever 102.9. I felt I was burning up. 911 call at 6 pm and was taken to hospital. Fever lasted all evening.  Was put on IV and antibiotic. Discharged 11:30 AM next day. October 7, 2005.
Numbness; This is a spontaneous report from a contactable consumer (Patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported, NDC number: Unknown) via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient stated I am calling because I have been experiencing like numbness (on an unspecified date) I don't know how to explain it feels like my hands joint (statement incomplete), to freak (further clarification unknown) you know and ever since I got the Pfizer injection, the first injection it started. And then call got disconnected. Call back was done to gather further details however, it was unsuccessful. Limited information was available over the call. The outcome of the event was unknown. Information on the lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
Developed extensive reddish brown, mostly macular, some-elevated rash, all over but mostly on truck, not itching, has little clear runny nose and mild cough, no fever, no red eyes, no SOB. Observe at home, CALADRYL lotion topical, advised oral hydroxyzine to give if itches.
Patient presented to vaccine clinic for 2nd Pfizer dose. Patient previously received 1st Pfizer dose on 12/18/21-  1st dose of Covid vaccine (Pfizer) 12/2021. Immediately after, patient reports having experienced increased blood pressure, feeling fainting, sensation of her throat closing, difficulty taking full breath, scratch throat. She also had a HA which lasted for 36 hours. Seen by allergist on 1/26/22- determined to not have allergy to PEG. Cleared to receive 2nd dose. Advised zyrtec for 3 days prior, day of, and 3 days after the vaccines. Patient received 2nd dose at approximately 0945. While in observation area @ approx. 1005, patient complained of feeling lightheaded and chest pain. Patient alert, oriented x 3. No wheezing noted. 911 called, patient notified and agreed to have further evaluation. Patient transported to ER via ambulance, mother present and accompanying patient to ER.
Case number PHEH2014US008202 is an initial spontaneous report received from a nurse on 23 Apr 2014. This report refers to a 20 years old male patient. His medical history and concomitant medications were not reported. It was reported that he received only the MenCYW-135 liquid component of MENVEO (batch number: not reported) intramuscularly on 22 Apr 2014 and did not receive the Men A lyophilized conjugate. No adverse events were reported following the maladministration.
Muscle spasm in right arm. Spasms happen randomly, some get more intense pain, it occurs in 3-4 places in the right arm near injection site. Feels like arm swells during spasm also.
The morning after I received my second vaccine I began feeling nauseated, then I started sweating profusely, and as I started to get a wash cloth to try to cool myself, I passed out.  I came to shortly thereafter, but was weak the rest of that day.  The second day after the vaccine I did go to work, but I battled my asthma all day.  I had to use my emergency inhaler twice, and at one point thought I was going to  have to go to the ER before getting it under control, but I did not have to.
Pt recvd 3 doses of Engerix-B, 3rd of which was given 06FEB90 & it was determined that pt failed to convert to HBSAB positive; Pt was given addtl doses of Engerix-B 02OCT90, & 28FEB90; & pt converted p/5th dose;
This case was reported by a healthcare professional via a sales representative and described the occurrence of seizure-like activity in a 57-year-old female subject who was vaccinated with FLUARIX (GlaxoSmithKline). Last year the subject was vaccinated with H1N1 (non-GSK) and experienced injection site redness. Concurrent medical conditions included penicillin allergy. There were no concurrent medications. It was reported that the subject received H1N1 (non-GSK) last year (2010) and an unspecified amount of time following, developed redness around the injection site and "felt funny". The subject commented that the events were mild enough that she did not do anything about them. Later, on 14 October 2011 at 08:00 the subject received a dose of (1st dose of the season) of FLUARIX at 0.5 ml in the left arm. On 14 October 2011, 30 minutes after vaccination with FLUARIX, the subject experienced seizure-like activity, eyesight quivering (vision was shaky and shifting from side to side), body shakes, looked pale, blue mouth triangle and clamminess. The subject also experienced elevated blood pressure. The subject was hospitalised and the healthcare professional considered the events were life threatening and clinically significant (or requiring intervention). The time to onset of elevated blood pressure was not specifically indicated, however, it began prior to the subject being released from the hospital. The subject was treated with BENADRYL and betamethasone and was sent home. At the time of reporting the subject still had elevated blood pressure, but the other events were resolved. The subject additionally reported that "the other day" she experienced some dizziness. Outcome of dizziness was not reported. In the reporter's opinion, the events of seizure-like activity, eyesight quivering, body shakes, looked pale, blue mouth triangle and clamminess were probably related to vaccination with FLUARIX.
Patient started to experience stiffness and numbness across her neck, shoulder and upper arm about a week after the administration of the Moderna shot. The pain and stiffness was not experienced on the arm that was administered but on the opposite arm and shoulder. She went to a chiropractor to help with the pain but he said that it is too inflamed to do any work on the shoulder.
pt recv vax 5/18/99 & 4hr p/vax began to scream so loudly that mom thought pt had broken a bone or something;pt began to turn yellow & foaming @ mouth-convuls like;to ER-no screaming but  moaning;eyes closed & looked like going into coma;
Child developed a fever of 104.6 F, nausea and vomitting during the night of 8/30/2007. Parent attempted to administer ibuprofen, but child was unable to keep it down due to the vomitting. On the 31st the child felt "wiped out and lousy, although the fever, nausea and vomitting was improving, but still occurring.  Mother reports child had low grade fever for three days and child did not feel better until 9/1/2007.
Breakthrough case admission after three vaccines Moderna 1/29/21 Lot# NONE;  1/29/21 Moderna NO LOT#; 1 1/1/21 Moderna Lot# 051F21A
The pt experienced a erythema at the injection site approximately 2.5 cm in diameter.
This 69-year-old female was brought in by ambulance with a one-day history of trouble eating that she described as difficulty chewing food secondary to lack of sensation in her tongue. She states that her problem started with numbness in her left hip starting around two months ago, which then spread much later to her abdomen and to her upper extremities. She feels that sit is getting worse now in the past ten days where she developed new weakness, balance problems and diminished sensation that spread to her face. The patient states that the trouble walking is secondary to her legs feeling heavy, her right side greater than her left side. She feels also uncoordinated when she walks and notes that the room seems to be spinning sometimes when she  her head. She denies any neck stiffening; only some right-sided muscle aches. Four days prior to admission, she was also in the emergency room for chest pain and otitis externa. Then three days ago, she was diagnosed with a urinary tract infection at the hospital. She states that she had a flu shot in November after which she developed same body aches, fatigue, shortness of breath and some back pain but felt that the symptoms were secondary to the shot. She states that she has a history of loss of control of urination only while coughing and no recent loss of function in the bowel or bladder function. She also relates that in 1998, she had an episode of ptosis which resolved on it's own. She had a Tensilon test at that time which was negative. Otherwise, she also was diagnosed with aspergillus pneumonia for which she sees Doctor and who prescribed PREDNISONE for her, the details of which she does not know.  7/30/09 Hospital records received DOS ER 12/6/01, Inpatient 12/09/01 to 12/20/01. Assessment: Fisher varient Guillain Barre syndrome. Patient presents with trouble eating, difficulty chewing food, lack of sensation in tongue. Numbness in hip, abdomen, and upper extremeties. Weakness, balance problems, diminished sensation that spread to face. Trouble walking, legs feeling heavy, right side greater than left. Room seems to be spinning, right sided muscle aches. Chest pain, otitis external, urinary tract infection. Fatigue, shortness of breath. Slurring speech. No two-point discrimination. Babinski abnormal. Deep tendon reflexes absent. Cerebellar clumsy heel to shin and finger to nose. Thigh pain.
89 yo male requested flu IZ. Immunization given. When secretary went to enter vz date, it appeared that pt had received flu immunization already 10/10. Notified advisor & pt. family. No reaction/voiced from pt.
periorbital swelling ;swelling of lips tightening  of lips ; BP elevated remained elevated more than 15mins Transported to Emergency Room for evaluation  Received Benedryl 50 mg PO
On the evening of 3/21/2000, the pt experienced severe pain/soreness in her left hand/wrist.